Glepaglutide, a novel glucagon-like peptide-2 agonist, has anti-inflammatory and mucosal regenerative effects in an experimental model of inflammatory bowel disease in rats. - Skarbaliene J; Mathiesen JM; Larsen BD; Thorkildsen C; Petersen YM (BMC gastroenterology, 2023)